Bozor qiymatining balans qiymatiga nisbati: scinai.com (SCNI)
Scinai Immunotherapeutics (SCNI) immunologlar va klinik sinovlar ekspertlarining jipslashgan jamoasiga tayanadi. Ushbu ilmiy asos barqaror nanotanalarni ishlab chiqishda brendning nufuzini mustahkamlaydi. Bozor kapitalizatsiyasining buxgalteriya qiymatiga nisbati aktivlarning baholanish tendentsiyasini aks ettiradi va hozirda ushbu ko'rsatkich 0.05 darajasida turibdi. Biroq, muvaffaqiyat tor doiradagi vaksina portfeliga bog'liq bo'lib, bu moliyalashtirish yetishmovchiligi va platformaning ishdan chiqishi kabi xatarlarni yuzaga keltiradi.
Scinai Immunotherapeutics Ltd (SCNI) - koʻrsatkichlar kesimi va moliyaviy hisobotlar
- aksiya kursi va ekspertlarning narx prognozi:
- kompaniyaning birjadagi kapitallashuv ko'rsatkichlari:
- balans kapitallashuvi bo'yicha ma'lumotlar:
- qarz majburiyatlari va likvidlik statistikasi:
Qarzning xususiy kapitalga nisbati Scinai Immunotherapeutics|SCNI - Uzoq muddatli qarzning kapitalga koeffitsiyenti|Qisqa muddatli qarzning o'z kapitaliga nisbati Scinai|SCNI - Kompaniyaning umumiy qarzi|Balans kapitallashuviga qarzlar Scinai|SCNI - Kompaniyaning uzoq muddatli qarzlari|Kompaniyaning qisqa muddatli majburiyatlari Scinai Immunotherapeutics|Tezkor likvidlik koeffitsiyenti scinai.com
- foyda va baholash multiplikatorlari ko'rsatkichlari:
Kompaniyaning asosiy tahlili:Scinai Immunotherapeutics - SCNI
Aktivlar sifatini baholash bozor narxi va kapitalning haqiqiy xarajati o'rtasidagi farqni tahlil qilishni talab qiladi. Ushbu ko'rsatkich investorlarning kompaniyaning sof aktivlaridan tashqari to'lashga tayyor bo'lgan premiumini o'lchaydi. Kompaniyaning bozor qiymatining uning balans aktivlariga nisbatini tahlil qilish orqali biznesning haddan tashqari qimmat yoki arzon baholanganini aniqlash mumkin. Ushbu tendentsiya Scinai Immunotherapeutics (SCNI) kompaniyasining kelgusidagi muvaffaqiyatiga bo'lgan bozor kutganlarini aks ettiradi. Scinai Immunotherapeutics rahbariyatining qat'iy xarajatlar nazorati kapitalizatsiya o'sayotgan bir paytda balans bazasini barqarorlashtirish imkonini beradi.
Raqobatchilar tahlili
ARGX: Bozor kapitallashuvining balans qiymatiga nisbati|BNTX - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati abivax.com|ADMA Biologics Inc - Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati PTGX|IMVT (Immunovant Therapeutics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati KNSA (Kiniksa Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga nisbati grifols.com GRFS|ADPT - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor qiymati CLDX (Celldex Therapeutics Inc)|Aurinia Pharma (AUPH) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati BioCryst Corp|VERA (Vera Therapeutics, Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati dianthustx.com|Kapitallashuvning sof aktivlarga nisbati PHVS (Pharvaris)|ABCL (AbCellera Biologics) - Balans qiymatiga nisbatan bozor qiymati|Bozor kapitallashuvining balans qiymatiga nisbati TRML (Tourmaline Corp)|Balans qiymatiga nisbatan bozor kapitallashuvi Precigen Corp (PGEN)|PHAR - Bozor qiymatining balans qiymatiga nisbati|nektar.com (NKTR) - Kapitallashuvning sof aktivlarga nisbati|Upstream Bio (UPB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Zenas Bio|Kapitallashuvning sof aktivlarga nisbati IMNM|Bozor kapitallashuvining balans qiymatiga nisbati Gossamer Bio Corp.|Bozor qiymatining balans qiymatiga nisbati KalVista Pharmaceuticals (KALV)|septerna.com - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati PVLA (Pieris Pharmaceuticals, Inc.)|Savara Inc (SVRA) - Bozor qiymatining balans qiymatiga koeffitsiyenti|RIGL - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi AnaptysBio Inc. ANAB|ATXS: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati engene.com|RAPT (RAPT Therapeutics) - Bozor kapitallashuvining balans qiymatiga nisbati|Aerovate (JBIO) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Aclaris (ACRS)|Kyverna Therapeutics, Inc - Kapitallashuvning balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati TLSA (Tiziana Life Sciences)|Bozor kapitallashuvining balans qiymatiga nisbati cabalettabio.com CABA|Ventyx Biosciences, Inc. - Bozor kapitallashuvining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi Theratechnologies, Inc. THTX|AVTX (Avalo Therapeutics Inc.) - Kapitallashuvning sof aktivlarga nisbati|Eledon Pharmaceuticals, Inc - Balans qiymatiga nisbatan bozor qiymati|AGEN (Agenus) - Bozor kapitallashuvining balans qiymatiga nisbati|climbbio.com (CLYM) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor qiymatining balans qiymatiga nisbati Zura Bio (ZURA)|Kapitallashuvning sof aktivlarga nisbati aTyr Pharma Inc ATYR|Bozor qiymatining balans qiymatiga nisbati Adagene Inc. ADAG|IMA - Kapitallashuvning sof aktivlarga nisbati|STTK: Kapitallashuvning sof aktivlarga nisbati|EQ - Bozor kapitallashuvining balans qiymatiga nisbati|connectbiopharm.com (CNTB) - Bozor qiymatining balans qiymatiga nisbati|Kapitallashuvning balans qiymatiga nisbati IMUX|Bozor qiymatining balans qiymatiga nisbati Atara Biotherapeutics, Inc.|Bozor qiymatining balans qiymatiga koeffitsiyenti InflaRx GmbH IFRX|Kapitallashuvning sof aktivlarga nisbati XFOR (X4 Pharmaceuticals)|Bozor kapitallashuvining balans qiymatiga multiplikatori ACET|Bozor kapitallashuvining balans qiymatiga nisbati CELU (Celularity)|Balans qiymatiga nisbatan bozor qiymati INMB|Barinthus Bio - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor qiymatining balans qiymatiga koeffitsiyenti Kezar Life Sciences Inc|SAB Biotherapeutics (SABS) - Bozor qiymatining balans qiymatiga nisbati|akaritx.com - Balans qiymatiga nisbatan bozor qiymati|ENLV (Enlivex Therapeutics Ltd) - Bozor kapitallashuvining balans qiymatiga nisbati|Bozor kapitallashuvining balans qiymatiga nisbati Q32 Bio Corp|Bozor qiymatining balans qiymatiga nisbati GeoVax Labs Inc (GOVX)|EDSA: Sof aktivlarga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati IBIO (iBio, Inc.)|Carisma Therapeutics Inc (CARM) - Bozor qiymatining balans qiymatiga koeffitsiyenti|XTLB: Kapitallashuvning sof aktivlarga nisbati|BOLT - Bozor kapitallashuvining balans qiymatiga nisbati|HCWB (hcwbiologics.com) - Kapitallashuvning sof aktivlarga nisbati|APVO: Bozor kapitallashuvining balans qiymatiga multiplikatori|AIM (AIM ImmunoTech Inc.) - Bozor kapitallashuvining balans qiymatiga nisbati|Aditxt Corp (ADTX) - Balans qiymatiga nisbatan bozor kapitallashuvi|Bozor kapitallashuvining balans qiymatiga nisbati GRI|Kapitallashuvning sof aktivlarga nisbati XORTX Therapeutics Inc XRTX|Bozor qiymatining balans qiymatiga nisbati ReShape Lifesciences HIND|Balans qiymatiga nisbatan bozor kapitallashuvi Revelation Biosciences Corp (REVB)|INDP - Bozor qiymatining balans qiymatiga nisbati|Balans qiymatiga nisbatan bozor kapitallashuvi CalciMedica, Inc. CALI|AFMD: Bozor kapitallashuvining balans qiymatiga nisbati|Kapitallashuvning sof aktivlarga nisbati Allakos|Bozor qiymatining balans qiymatiga nisbati HOOKIPA Pharma, Inc.|Kapitallashuvning balans qiymatiga nisbati IGMS (IGM Bio)|Bozor kapitallashuvining balans qiymatiga nisbati ITOS|Balans qiymatiga nisbatan bozor kapitallashuvi oceanbiomedical.com|Bozor qiymatining balans qiymatiga nisbati TC BioPharm TCBP|THRD (Third Harmonic Bio Inc.) - Sof aktivlarga nisbatan bozor kapitallashuvi